Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2019 10:33 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Resignation of Chief Business Development Officer

Oslo (Norway), 28 February 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that its Chief Business Development Officer (CBDO), Gaël L’Hévéder has resigned...
February 25, 2019 04:53 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Capital increase registered and listing of new shares

Oslo, Norway, 25 February 2019. Reference is made to the previous announcements by PCI Biotech Holding ASA ("PCI Biotech" or the "Company") in respect of the issuance of 61,000 new shares following...
February 20, 2019 12:17 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital

Oslo (Norway), 20 February 2019 – Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”). 1. ...
February 13, 2019 01:30 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Fourth quarter and preliminary 2018 results

Oslo (Norway), 13 February 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim fourth quarter and preliminary 2018 result. Please find enclosed the...
February 05, 2019 07:56 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Invitation to fourth quarter and preliminary 2018 result presentation

Oslo, Norway, 05 February 2019 - PCI Biotech invites to a presentation of the company's fourth quarter and preliminary 2018 report on Wednesday 13 February 2019 at Oslo Cancer Cluster Innovation Park....
December 20, 2018 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Preliminary confirmation of safety read-out from the fimaChem Phase I extension study in bile duct cancer

Oslo (Norway), 20 December 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced preliminary confirmation that the safety endpoint has been reached in the Phase I...
December 18, 2018 08:55 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company

Oslo (Norway), 18 December 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with an undisclosed...
November 13, 2018 01:30 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Third quarter 2018 results

Oslo (Norway), 13 November 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim third quarter 2018 result. Please find enclosed the report and...
November 06, 2018 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Invitation to third quarter 2018 presentation

Oslo, Norway, 06 November 2018 - PCI Biotech invites to a presentation of the company's third quarter 2018 report on Tuesday 13 November 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday...
October 24, 2018 05:01 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Capital increase registered and listing of new shares

Oslo, Norway, 24 October 2018. Reference is made to the previous announcements by PCI Biotech Holding ASA ("PCI Biotech" or the "Company") in respect of the issuance of 170,000 new shares following...